 | • レポートコード：MRC2-11QY04096 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は希少疾患のグローバル市場について調査・分析したレポートです。種類別（自己免疫疾患、遺伝性疾患、血液疾患、癌、成長障害、心血管疾患、神経障害、呼吸器疾患、消化器疾患、眼疾患）市場規模、用途別（病院・診療所、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別希少疾患の競争状況、市場シェア ・世界の希少疾患市場：種類別市場規模 2015年-2020年（自己免疫疾患、遺伝性疾患、血液疾患、癌、成長障害、心血管疾患、神経障害、呼吸器疾患、消化器疾患、眼疾患） ・世界の希少疾患市場：種類別市場規模予測 2021年-2026年（自己免疫疾患、遺伝性疾患、血液疾患、癌、成長障害、心血管疾患、神経障害、呼吸器疾患、消化器疾患、眼疾患） ・世界の希少疾患市場：用途別市場規模 2015年-2020年（病院・診療所、研究所） ・世界の希少疾患市場：用途別市場規模予測 2021年-2026年（病院・診療所、研究所） ・北米の希少疾患市場分析：米国、カナダ ・ヨーロッパの希少疾患市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの希少疾患市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の希少疾患市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの希少疾患市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol-Myers Squibb、Novartis、Celgene、Roche、Pfizer、Alexion、Sanofi、Vertex Pharmaceuticals、GlaxoSmithKline、Merck、Abbvie ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig’s disease, and Tourette’s syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or “gigantism.” Some diseases have patient populations of fewer than a hundred.
New rare diseases are discovered every year. Most are inherited and caused by alterations or defects in genes (mutations). Others can be acquired as a result of environmental and toxic conditions. Genes are pieces of DNA, part of the code that determines the traits and individual characteristics of all living things.
Market Analysis and Insights: Global Orphan Diseases Market
The global Orphan Diseases market size is projected to reach US$ 268.4 million by 2026, from US$ 233.7 million in 2020, at a CAGR of 14.1%% during 2021-2026.
Global Orphan Diseases Scope and Market Size
Orphan Diseases market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Orphan Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bristol-Myers Squibb
Novartis
Celgene
Roche
Pfizer
Alexion
Sanofi
Vertex Pharmaceuticals
GlaxoSmithKline
Merck
Abbvie
Market segment by Type, the product can be split into
Autoimmune Disorders
Genetic Disorders
Blood Disorders
Cancer
Growth Disorder
Cardiovascular Diseases
Neurological Disorders
Respiratory Disorders
Digestive Disorders
Eye Disorders
Market segment by Application, split into
Hospitals And Clinics
Research Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Orphan Diseases Revenue
1.4 Market by Type
1.4.1 Global Orphan Diseases Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Autoimmune Disorders
1.4.3 Genetic Disorders
1.4.4 Blood Disorders
1.4.5 Cancer
1.4.6 Growth Disorder
1.4.7 Cardiovascular Diseases
1.4.8 Neurological Disorders
1.4.9 Respiratory Disorders
1.4.10 Digestive Disorders
1.4.11 Eye Disorders
1.5 Market by Application
1.5.1 Global Orphan Diseases Market Share by Application: 2020 VS 2026
1.5.2 Hospitals And Clinics
1.5.3 Research Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Orphan Diseases Market Perspective (2015-2026)
2.2 Global Orphan Diseases Growth Trends by Regions
2.2.1 Orphan Diseases Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Orphan Diseases Historic Market Share by Regions (2015-2020)
2.2.3 Orphan Diseases Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Orphan Diseases Market Growth Strategy
2.3.6 Primary Interviews with Key Orphan Diseases Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Orphan Diseases Players by Market Size
3.1.1 Global Top Orphan Diseases Players by Revenue (2015-2020)
3.1.2 Global Orphan Diseases Revenue Market Share by Players (2015-2020)
3.1.3 Global Orphan Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Orphan Diseases Market Concentration Ratio
3.2.1 Global Orphan Diseases Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Orphan Diseases Revenue in 2019
3.3 Orphan Diseases Key Players Head office and Area Served
3.4 Key Players Orphan Diseases Product Solution and Service
3.5 Date of Enter into Orphan Diseases Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Orphan Diseases Historic Market Size by Type (2015-2020)
4.2 Global Orphan Diseases Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Orphan Diseases Market Size by Application (2015-2020)
5.2 Global Orphan Diseases Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Orphan Diseases Market Size (2015-2020)
6.2 Orphan Diseases Key Players in North America (2019-2020)
6.3 North America Orphan Diseases Market Size by Type (2015-2020)
6.4 North America Orphan Diseases Market Size by Application (2015-2020)
7 Europe
7.1 Europe Orphan Diseases Market Size (2015-2020)
7.2 Orphan Diseases Key Players in Europe (2019-2020)
7.3 Europe Orphan Diseases Market Size by Type (2015-2020)
7.4 Europe Orphan Diseases Market Size by Application (2015-2020)
8 China
8.1 China Orphan Diseases Market Size (2015-2020)
8.2 Orphan Diseases Key Players in China (2019-2020)
8.3 China Orphan Diseases Market Size by Type (2015-2020)
8.4 China Orphan Diseases Market Size by Application (2015-2020)
9 Japan
9.1 Japan Orphan Diseases Market Size (2015-2020)
9.2 Orphan Diseases Key Players in Japan (2019-2020)
9.3 Japan Orphan Diseases Market Size by Type (2015-2020)
9.4 Japan Orphan Diseases Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Orphan Diseases Market Size (2015-2020)
10.2 Orphan Diseases Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Orphan Diseases Market Size by Type (2015-2020)
10.4 Southeast Asia Orphan Diseases Market Size by Application (2015-2020)
11 India
11.1 India Orphan Diseases Market Size (2015-2020)
11.2 Orphan Diseases Key Players in India (2019-2020)
11.3 India Orphan Diseases Market Size by Type (2015-2020)
11.4 India Orphan Diseases Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Orphan Diseases Market Size (2015-2020)
12.2 Orphan Diseases Key Players in Central & South America (2019-2020)
12.3 Central & South America Orphan Diseases Market Size by Type (2015-2020)
12.4 Central & South America Orphan Diseases Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview
13.1.3 Bristol-Myers Squibb Orphan Diseases Introduction
13.1.4 Bristol-Myers Squibb Revenue in Orphan Diseases Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Orphan Diseases Introduction
13.2.4 Novartis Revenue in Orphan Diseases Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Celgene
13.3.1 Celgene Company Details
13.3.2 Celgene Business Overview
13.3.3 Celgene Orphan Diseases Introduction
13.3.4 Celgene Revenue in Orphan Diseases Business (2015-2020)
13.3.5 Celgene Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Orphan Diseases Introduction
13.4.4 Roche Revenue in Orphan Diseases Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Orphan Diseases Introduction
13.5.4 Pfizer Revenue in Orphan Diseases Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Alexion
13.6.1 Alexion Company Details
13.6.2 Alexion Business Overview
13.6.3 Alexion Orphan Diseases Introduction
13.6.4 Alexion Revenue in Orphan Diseases Business (2015-2020)
13.6.5 Alexion Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Orphan Diseases Introduction
13.7.4 Sanofi Revenue in Orphan Diseases Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Vertex Pharmaceuticals
13.8.1 Vertex Pharmaceuticals Company Details
13.8.2 Vertex Pharmaceuticals Business Overview
13.8.3 Vertex Pharmaceuticals Orphan Diseases Introduction
13.8.4 Vertex Pharmaceuticals Revenue in Orphan Diseases Business (2015-2020)
13.8.5 Vertex Pharmaceuticals Recent Development
13.9 GlaxoSmithKline
13.9.1 GlaxoSmithKline Company Details
13.9.2 GlaxoSmithKline Business Overview
13.9.3 GlaxoSmithKline Orphan Diseases Introduction
13.9.4 GlaxoSmithKline Revenue in Orphan Diseases Business (2015-2020)
13.9.5 GlaxoSmithKline Recent Development
13.10 Merck
13.10.1 Merck Company Details
13.10.2 Merck Business Overview
13.10.3 Merck Orphan Diseases Introduction
13.10.4 Merck Revenue in Orphan Diseases Business (2015-2020)
13.10.5 Merck Recent Development
13.11 Abbvie
10.11.1 Abbvie Company Details
10.11.2 Abbvie Business Overview
10.11.3 Abbvie Orphan Diseases Introduction
10.11.4 Abbvie Revenue in Orphan Diseases Business (2015-2020)
10.11.5 Abbvie Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Orphan Diseases Key Market Segments
Table 2. Key Players Covered: Ranking by Orphan Diseases Revenue
Table 3. Ranking of Global Top Orphan Diseases Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Orphan Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Autoimmune Disorders
Table 6. Key Players of Genetic Disorders
Table 7. Key Players of Blood Disorders
Table 8. Key Players of Cancer
Table 9. Key Players of Growth Disorder
Table 10. Key Players of Cardiovascular Diseases
Table 11. Key Players of Neurological Disorders
Table 12. Key Players of Respiratory Disorders
Table 13. Key Players of Digestive Disorders
Table 14. Key Players of Eye Disorders
Table 15. Global Orphan Diseases Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Orphan Diseases Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Orphan Diseases Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Orphan Diseases Market Share by Regions (2015-2020)
Table 19. Global Orphan Diseases Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Orphan Diseases Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Orphan Diseases Market Growth Strategy
Table 25. Main Points Interviewed from Key Orphan Diseases Players
Table 26. Global Orphan Diseases Revenue by Players (2015-2020) (Million US$)
Table 27. Global Orphan Diseases Market Share by Players (2015-2020)
Table 28. Global Top Orphan Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orphan Diseases as of 2019)
Table 29. Global Orphan Diseases by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Orphan Diseases Product Solution and Service
Table 32. Date of Enter into Orphan Diseases Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Orphan Diseases Market Size by Type (2015-2020) (Million US$)
Table 35. Global Orphan Diseases Market Size Share by Type (2015-2020)
Table 36. Global Orphan Diseases Revenue Market Share by Type (2021-2026)
Table 37. Global Orphan Diseases Market Size Share by Application (2015-2020)
Table 38. Global Orphan Diseases Market Size by Application (2015-2020) (Million US$)
Table 39. Global Orphan Diseases Market Size Share by Application (2021-2026)
Table 40. North America Key Players Orphan Diseases Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Orphan Diseases Market Share (2019-2020)
Table 42. North America Orphan Diseases Market Size by Type (2015-2020) (Million US$)
Table 43. North America Orphan Diseases Market Share by Type (2015-2020)
Table 44. North America Orphan Diseases Market Size by Application (2015-2020) (Million US$)
Table 45. North America Orphan Diseases Market Share by Application (2015-2020)
Table 46. Europe Key Players Orphan Diseases Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Orphan Diseases Market Share (2019-2020)
Table 48. Europe Orphan Diseases Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Orphan Diseases Market Share by Type (2015-2020)
Table 50. Europe Orphan Diseases Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Orphan Diseases Market Share by Application (2015-2020)
Table 52. China Key Players Orphan Diseases Revenue (2019-2020) (Million US$)
Table 53. China Key Players Orphan Diseases Market Share (2019-2020)
Table 54. China Orphan Diseases Market Size by Type (2015-2020) (Million US$)
Table 55. China Orphan Diseases Market Share by Type (2015-2020)
Table 56. China Orphan Diseases Market Size by Application (2015-2020) (Million US$)
Table 57. China Orphan Diseases Market Share by Application (2015-2020)
Table 58. Japan Key Players Orphan Diseases Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Orphan Diseases Market Share (2019-2020)
Table 60. Japan Orphan Diseases Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Orphan Diseases Market Share by Type (2015-2020)
Table 62. Japan Orphan Diseases Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Orphan Diseases Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Orphan Diseases Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Orphan Diseases Market Share (2019-2020)
Table 66. Southeast Asia Orphan Diseases Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Orphan Diseases Market Share by Type (2015-2020)
Table 68. Southeast Asia Orphan Diseases Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Orphan Diseases Market Share by Application (2015-2020)
Table 70. India Key Players Orphan Diseases Revenue (2019-2020) (Million US$)
Table 71. India Key Players Orphan Diseases Market Share (2019-2020)
Table 72. India Orphan Diseases Market Size by Type (2015-2020) (Million US$)
Table 73. India Orphan Diseases Market Share by Type (2015-2020)
Table 74. India Orphan Diseases Market Size by Application (2015-2020) (Million US$)
Table 75. India Orphan Diseases Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Orphan Diseases Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Orphan Diseases Market Share (2019-2020)
Table 78. Central & South America Orphan Diseases Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Orphan Diseases Market Share by Type (2015-2020)
Table 80. Central & South America Orphan Diseases Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Orphan Diseases Market Share by Application (2015-2020)
Table 82. Bristol-Myers Squibb Company Details
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Product
Table 85. Bristol-Myers Squibb Revenue in Orphan Diseases Business (2015-2020) (Million US$)
Table 86. Bristol-Myers Squibb Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Product
Table 90. Novartis Revenue in Orphan Diseases Business (2015-2020) (Million US$)
Table 91. Novartis Recent Development
Table 92. Celgene Company Details
Table 93. Celgene Business Overview
Table 94. Celgene Product
Table 95. Celgene Revenue in Orphan Diseases Business (2015-2020) (Million US$)
Table 96. Celgene Recent Development
Table 97. Roche Company Details
Table 98. Roche Business Overview
Table 99. Roche Product
Table 100. Roche Revenue in Orphan Diseases Business (2015-2020) (Million US$)
Table 101. Roche Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Product
Table 105. Pfizer Revenue in Orphan Diseases Business (2015-2020) (Million US$)
Table 106. Pfizer Recent Development
Table 107. Alexion Company Details
Table 108. Alexion Business Overview
Table 109. Alexion Product
Table 110. Alexion Revenue in Orphan Diseases Business (2015-2020) (Million US$)
Table 111. Alexion Recent Development
Table 112. Sanofi Company Details
Table 113. Sanofi Business Overview
Table 114. Sanofi Product
Table 115. Sanofi Revenue in Orphan Diseases Business (2015-2020) (Million US$)
Table 116. Sanofi Recent Development
Table 117. Vertex Pharmaceuticals Business Overview
Table 118. Vertex Pharmaceuticals Product
Table 119. Vertex Pharmaceuticals Company Details
Table 120. Vertex Pharmaceuticals Revenue in Orphan Diseases Business (2015-2020) (Million US$)
Table 121. Vertex Pharmaceuticals Recent Development
Table 122. GlaxoSmithKline Company Details
Table 123. GlaxoSmithKline Business Overview
Table 124. GlaxoSmithKline Product
Table 125. GlaxoSmithKline Revenue in Orphan Diseases Business (2015-2020) (Million US$)
Table 126. GlaxoSmithKline Recent Development
Table 127. Merck Company Details
Table 128. Merck Business Overview
Table 129. Merck Product
Table 130. Merck Revenue in Orphan Diseases Business (2015-2020) (Million US$)
Table 131. Merck Recent Development
Table 132. Abbvie Company Details
Table 133. Abbvie Business Overview
Table 134. Abbvie Product
Table 135. Abbvie Revenue in Orphan Diseases Business (2015-2020) (Million US$)
Table 136. Abbvie Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Orphan Diseases Market Share by Type: 2020 VS 2026
Figure 2. Autoimmune Disorders Features
Figure 3. Genetic Disorders Features
Figure 4. Blood Disorders Features
Figure 5. Cancer Features
Figure 6. Growth Disorder Features
Figure 7. Cardiovascular Diseases Features
Figure 8. Neurological Disorders Features
Figure 9. Respiratory Disorders Features
Figure 10. Digestive Disorders Features
Figure 11. Eye Disorders Features
Figure 12. Global Orphan Diseases Market Share by Application: 2020 VS 2026
Figure 13. Hospitals And Clinics Case Studies
Figure 14. Research Laboratories Case Studies
Figure 15. Orphan Diseases Report Years Considered
Figure 16. Global Orphan Diseases Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Orphan Diseases Market Share by Regions: 2020 VS 2026
Figure 18. Global Orphan Diseases Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Orphan Diseases Market Share by Players in 2019
Figure 21. Global Top Orphan Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orphan Diseases as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Orphan Diseases Revenue in 2019
Figure 23. North America Orphan Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Orphan Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Orphan Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Orphan Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Orphan Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Orphan Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Orphan Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed
神経精神障害・治療の世界市場（～2026年） Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions…- パニック障害の世界市場（～2026年） Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks. Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used inc…
- 後天性孤児造血疾患治療薬の世界市場（～2026年） Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body’s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack …
- 代謝障害治療薬の世界市場（～2026年） Metabolic Disorders Therapeutics is a drug used to treat the symptoms of metabolic disorders caused by a variety of causes. Due to the increasing pressure of modern life and the spread of unhealthy lifestyles, the global metabolic disorder treatment market will continue to grow strongly during the f…
- 破壊的行動障害（DBD）の世界市場（～2026年） Disruptive Behavior Disorders (DBD) is behavioral disorders characterized by hostile and defiant behaviors that children and adolescents direct towards others. The global disruptive behavior disorders market is being driven by the rise in the number of comorbid disorders, active involvement of NGO a…